ArticleBritish journal of pharmacology2003

The preferential beta3-adrenoceptor agonist BRL 37344 increases force via beta1-/beta2-adrenoceptors and induces endothelial nitric oxide synthase via beta3-adrenoceptors in human atrial myocardium.

C Pott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.